|
Nexia Announces First Quarter 2006 results Friday October 28, 8:00 am ET (in Canadian dollars) MONTREAL, Oct. 28 /CNW Telbec/ - Nexia Biotechnologies Inc. ("Nexia") (NEX: NXB-H.V) today announced its August 31, 2005 first quarter 2006 results. The loss for the quarter ended August 31, 2005 was $125,000 ($0.01 per share) compared to a net loss of $2.5 million ($0.11 per share) for the quarter ended August 31, 2004. The substantial variance was due to the reductions in spending, across all categories as a result of substantially reduced operations, after the completed, previously disclosed, asset sale transaction with PharmAthene Inc. ABOUT NEXIA For more information, please visit Nexia`s website at www.nexiabiotech.com . Nexia`s complete continuing disclosure documents, including: the first quarter 2006 report and interim financial statements, the 2005 Annual Report, the MD&A and consolidated financial statements for the fiscal 2005 can be accessed through Company`s securities filings at www.sedar.com . FORWARD-LOOKING STATEMENT AND OTHER IMPORTANT INFORMATION Except for the historical information presented herein, matters discussed herein may constitute forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "believes"; "anticipates"; "intends"; "plans"; "expects"; "estimates"; or similar statements are forward-looking statements. Such statements reflect management`s current views and are based on certain assumptions. Actual results could differ materially from those currently anticipated as a result of a number of factors. Nexia specifically disclaims any obligation to update these forward-looking statements. Nexia assumes no responsibility with respect to any information contained herein relating to any entity other than itself. Website addresses referred to herein are provided for convenience purposes only and information contained therein is not incorporated herein by reference, nor does Nexia assume any responsibility in connection therewith. For more information, please visit www.sedar.com . BioSteel(R) is a registered trademark of Nexia Biotechnologies Inc. in Canada. For further information William C. Garriock, President, CEO and Chairman of the Board or Dejan Ristic, Chief Financial Officer, (514) 58-NEXIA, investors@nexiabiotech.com -------------------------------------------------------------------------------- Source: NEXIA BIOTECHNOLOGIES INC. |
|
| aus der Diskussion: | Nexia Biotech- große Zukunftsaussichten |
| Autor (Datum des Eintrages): | Bombenleger (22.11.05 10:56:39) |
| Beitrag: | 38 von 43 (ID:18935141) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |